// Biotech and Pharma Therapeutics
Gain Therapeutics to Participate in AI Driven Drug Discovery Summit
November 29, 2023 / AI / Drug Discovery / Gain Therapeutics
Lilly shines light on protein-protein interaction, inking backloaded $660M Prism drug discovery pact
November 29, 2023 / Eli Lilly / Drug Discovery / Undruggable Targets / Deal
BioMarin secures hemophilia gene therapy coverage in Germany
November 29, 2023 / BioMarin / Germany / Gene Therapy
Novartis Raises Growth Target, Trims Pipeline Under ‘Pure-Play’ Strategy
November 29, 2023 / Novartis / Swiss Pharma / Neuroscience
MHRA launches online eligibility checker tool via the IRP
November 27, 2023 / MHRA / IRP / Healthcare
// 4th Industrial Revolution
AI Tool Uses Epigenetic Factors to Predict Cancer Survival Outcomes
November 28, 2023 / AI / Cancer / UCLA Health
New Platform Solves Key Problems in Targeted Drug Delivery
November 27, 2023 / Drug Delivery / Gene Therapies / Cell Therapies
Navigating the path to AI at scale
November 27, 2023 / AI / Healthcare
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
November 29, 2023 / Prisma Health / Health System / Drug Development
Researchers advance ‘placenta-on-a-chip’ with sensing, imaging technology
November 28, 2023 / Placenta / Infant / New Tech
// Business & Markets
Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers
November 29, 2023 / Eli Lilly / Protein Blockers / Preclinical
Boehringer bets $509M on Phenomic’s tumor-targeting tech, as AI biotech plans for busy year
November 29, 2023 / Phenomic AI / Boehringer Ingelheim /Biotech Deals / Drug Targets
Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront
November 29, 2023 / Ascendis Pharma / Teijin Pharma / Skytrofa / Hormone Replacement Therapy
Mark Cuban Cost Plus Drug Company announces two partnerships
November 28, 2023 / Mark Cuban / Cost Plus Drug Company / PharmaRX’s
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
November 30, 2023 / AbbVie / ADC / ImmunoGen / Antibody-drug
// Legal & Regulatory
After long journey, Karuna’s schizophrenia drug gets FDA decision date
November 29, 2023 / Karuna Therapeutics / Schizophrenia / KarXT / FDA
FDA investigates ‘serious risk’ of secondary cancer following CAR-T treatment
November 28, 2023 / Drug Safety / Cell Therapy / Gene Therapy / FDA / CAR-T
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success
November 27, 2023 / Sanofi / Regeneron / COPD / Phase 3 / Respiratory
Asep’s AI-based sepsis technology receives patent approval in US
November 27, 2023 / AI / Asep / Patent Approval / New Tech
US FDA investigating safety risk of CAR-T cancer therapies
November 28, 2023 / FDA / CAR-T / Cancer
// Research & Development
Jazz halts sleep disorder med trial over ‘visual disturbances’ and CV effects
November 29, 2023 / Jazz Pharma / Takeda / Narcolepsy / Sleep Drugs
Clinical trial reveals positive results for treating children with rare gliomas
November 28, 2023 / Clinical Trials / Rare Gliomos / BRAF
Xenon drug misses main goal of depression study
November 27, 2023 / Xenon Drug / Mental Health / Depression
GSK cancer drug Blenrep gets surprise trial win
November 27, 2023 / GSK Cancer Drug / Myeloma Drugs / Blenrep / Oncology
New research supports potential link between low-level lead exposure and liver injury
November 27, 2023 / Liver Injury / Lead Exposure
// Politics
Texas Attorney General Ken Paxton sues Pfizer, alleges pharma giant lied about COVID vaccine efficacy
November 30, 2023 / Attorney General / Pfizer / Vaccine
White House, Sanofi and AZ take steps to head off RSV antibody shortage for 2024-25 virus season
November 29, 2023 / Sanofi / AstraZeneca / Joe Biden / Beyfortus
B.C. in court against pharma companies in bid to certify opioid class-action lawsuit
November 27, 2023 / Canada / Opioid Crisis
The B.C. Supreme Court should certify a class-action lawsuit against opioid makers on behalf of all provinces and territories to save time and money on what would otherwise be 13 nearly identical actions, a B.C. government lawyer says.
Purdue Pharma bankruptcy in limbo as Supreme Court prepares to hear arguments
November 29, 2023 / Purdue Pharma / Bankruptcy
Canada bans arm of drugmaker Teva from federal contracts over U.S. price-fixing scheme
November 27, 2023 / Canada / Drugmakers / Teva